Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study
Alyaa Ramadan1,4, Frederic Lagarce1,3, Anne Tessier-Marteau2, Olivier Thomas1, Pierre Legras5, Laurent Macchi2, Patrick Saulnier1, Jean Pierre Benoit1,31LUNAM Université, Ingénierie de la Vectorisation Particulaire, Inserm U-646, Angers, France; 2Hematology Department,...
Guardado en:
Autores principales: | Ramadan A, Lagarce F, Tessier-Marteau A, Thomas O, Legras P, Macchi L, Saulnier P, Benoit JP |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1375d1ca280b41f7b0ea481e1a752324 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery
por: Groo AC, et al.
Publicado: (2013) -
Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide
por: Messaoudi K, et al.
Publicado: (2014) -
Lipidic nanocapsule drug delivery: neuronal protection for cochlear implant optimization
por: Meyer H, et al.
Publicado: (2012) -
The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein–Barr virus disease
por: Heather E Vezina, et al.
Publicado: (2009) -
Predisposition for borderline personality disorder with comorbid major depression is associated with that for polycystic ovary syndrome in female Japanese population
por: Kawamura S, Maesawa C, Nakamura K, Nakayama K, Morita M, Hiruma Y, Yoshida T, Sakai A, Masuda T
Publicado: (2011)